Form 4: Casdin Group Reports 3,007,164 Indirect WGS Shares After Sale
Rhea-AI Filing Summary
Casdin-related parties reported insider sales of GeneDx Holdings Corp. (WGS) common stock on 08/22/2025. The filing shows a sale of 500,000 shares of Class A common stock at $120.9039 per share. After the reported transactions, the group reports beneficial ownership of 3,007,164 shares on an indirect basis. The Form 4 lists additional holdings and dispositions across related entities and individuals, including direct ownership of 20,518 shares and indirect positions of 19,247 and 333,144 shares, with explanatory footnotes describing relationships among Casdin Capital, Casdin Partners funds, the GP and Eli Casdin.
Positive
- None.
Negative
- Reported sale of 500,000 Class A shares at $120.9039 on 08/22/2025 by Casdin-affiliated reporting persons
- Insider disposition occurred despite remaining significant indirect holdings of 3,007,164 shares, indicating partial liquidation by a 10% owner
Insights
TL;DR: Significant insider sale disclosed—500,000 Class A shares sold at $120.9039; group still reports multi-million share indirect holdings.
The Form 4 documents a substantial disposition by reporting persons affiliated with Casdin on 08/22/2025. A sale of 500,000 Class A shares at $120.9039 is explicitly reported. The filing also reconciles multiple direct and indirect holdings across the Master Fund, GP and related entities, resulting in 3,007,164 shares reported as indirectly owned after these transactions. This disclosure clarifies ownership structure but does not include company-wide share counts or context to quantify percent ownership, so materiality relative to total float cannot be determined from this filing alone.
TL;DR: Filing shows coordinated reporting by multiple affiliated persons and clarifies indirect ownership and voting discretion.
The Form 4 appropriately attributes holdings among Casdin Capital, the Master Fund, the GP, and Eli Casdin, with footnotes explaining direct versus indirect beneficial ownership and shared voting/investment discretion via CMLS Holdings. Signatures from each reporting entity are present. The filing contains standard disclaimers of beneficial ownership limited to pecuniary interest. No additional governance actions or changes to board composition are disclosed.
FAQ
What insider transaction did the Form 4 for WGS report?
Who filed the Form 4 for GeneDx (WGS)?
How many WGS shares does the group report owning after the sale?
Are there other holdings or dispositions disclosed in the filing?
Does the Form 4 explain the relationships among the reporting persons?
Does this Form 4 disclose percent ownership of the company or total share count?